Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men.

PubWeight™: 4.68‹?› | Rank: Top 1%

🔗 View Article (PMID 6148471)

Published in Lancet on September 29, 1984

Authors

J J Goedert, M G Sarngadharan, R J Biggar, S H Weiss, D M Winn, R J Grossman, M H Greene, A J Bodner, D L Mann, D M Strong

Articles citing this

The San Francisco Men's Health Study: III. Reduction in human immunodeficiency virus transmission among homosexual/bisexual men, 1982-86. Am J Public Health (1987) 5.78

HIV infection in homosexual and bisexual men 18 to 29 years of age: the San Francisco Young Men's Health Study. Am J Public Health (1994) 5.18

Reliability of self-reported sexual behavior risk factors for HIV infection in homosexual men. Public Health Rep (1988) 2.93

Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome. J Virol (1986) 2.65

Phorbol ester enhances human immunodeficiency virus-promoted gene expression and acts on a repeated 10-base-pair functional enhancer element. Mol Cell Biol (1987) 2.42

Sexual lifestyle and clinical findings related to HTLV-III/LAV status in homosexual men. Genitourin Med (1986) 2.14

The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells. Can Med Assoc J (1985) 2.11

Human immunodeficiency virus infection, hepatitis B virus infection, and sexual behaviour of women attending a genitourinary medicine clinic. Br Med J (Clin Res Ed) (1988) 2.06

Recombinant polypeptide from the endonuclease region of the acquired immune deficiency syndrome retrovirus polymerase (pol) gene detects serum antibodies in most infected individuals. J Virol (1986) 2.04

The Vancouver Lymphadenopathy-AIDS Study: 6. HIV seroconversion in a cohort of homosexual men. CMAJ (1986) 2.01

Trends in sexual behaviour and risk factors for HIV infection among homosexual men, 1984-7. BMJ (1989) 1.97

Construction and use of a replication-competent human immunodeficiency virus (HIV-1) that expresses the chloramphenicol acetyltransferase enzyme. Proc Natl Acad Sci U S A (1989) 1.96

Factors affecting seropositivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDS. Genitourin Med (1986) 1.77

The natural history of human T lymphotropic virus-III infection: the cause of AIDS. Br Med J (Clin Res Ed) (1986) 1.69

The Vancouver Lymphadenopathy-AIDS Study: 3. Relation of HTLV-III seropositivity, immune status and lymphadenopathy. Can Med Assoc J (1985) 1.59

The Vancouver Lymphadenopathy-AIDS Study: 1. Persistent generalized lymphadenopathy. Can Med Assoc J (1985) 1.47

Behavioral risk factors for HIV infection among homosexual men at a Boston community health center. Am J Public Health (1988) 1.37

The Vancouver Lymphadenopathy-AIDS Study: 2. Seroepidemiology of HTLV-III antibody. Can Med Assoc J (1985) 1.31

Risk profiles for genital infection in women. Genitourin Med (1993) 1.18

Sexual seroadaptation: lessons for prevention and sex research from a cohort of HIV-positive men who have sex with men. PLoS One (2010) 1.18

Mechanisms of virus-induced immune suppression. Can Med Assoc J (1985) 1.14

Antibody response to human immunodeficiency virus in homosexual men. Relation of antibody specificity, titer, and isotype to clinical status, severity of immunodeficiency, and disease progression. J Clin Invest (1987) 1.09

Hormone pattern in pharmacologically feminized male transsexuals in the California State prison system. J Natl Med Assoc (1992) 0.92

Circulating cytokine levels, Epstein-Barr viremia, and risk of acquired immunodeficiency syndrome-related non-Hodgkin lymphoma. Am J Hematol (2011) 0.91

Time of exposure and risk of HIV infection in homosexual partners of men with AIDS. Am J Public Health (1988) 0.91

Increased levels of circulating cytokines with HIV-related immunosuppression. AIDS Res Hum Retroviruses (2011) 0.90

Update on AIDS for the family physician. Can Fam Physician (1987) 0.88

Effects of incarceration on HIV-infected individuals. J Natl Med Assoc (1996) 0.83

Prevalence of antibody to LAV/HTLV-III among homosexual men in Seattle. Am J Public Health (1986) 0.81

Immunological study of the rectal mucosa of men with and without human immunodeficiency virus infection. Gut (1987) 0.80

The Vancouver Lymphadenopathy-AIDS Study: 5. Antecedent behavioural, clinical and laboratory findings in patients with AIDS and HIV-seropositive controls. CMAJ (1986) 0.79

Increased suppressor T cells in probable transmitters of human immunodeficiency virus infection. Am J Public Health (1989) 0.78

Brachioproctic eroticism and transmission of retrovirus associated with acquired immune deficiency syndrome (AIDS). Genitourin Med (1986) 0.77

In men at risk of HIV infection, IgM, IgG1, IgG3, and IgA reach the human foreskin epidermis. Mucosal Immunol (2015) 0.77

Neuropsychiatric and psychological aspects related to human immuno deficincy virus (hiv) infection. Indian J Psychiatry (1992) 0.76

Progressive cellular immune impairment leading to development of AIDS: two-year prospective study of HIV infection in drug addicts. Clin Exp Immunol (1988) 0.75

AIDS-related behavioral research and nursing. J Natl Med Assoc (1991) 0.75

HTLV-III infection in spouses of haemophiliacs. Br Med J (Clin Res Ed) (1985) 0.75

Screening for Cancer in Persons Living with HIV Infection. Trends Cancer (2016) 0.75

Sequential HTLV-III antibody studies in Danish homosexual men. Arch Dermatol Res (1987) 0.75

Articles by these authors

Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science (1984) 33.32

Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science (1996) 15.63

Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science (1984) 11.30

Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med (1996) 10.49

HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science (1999) 8.11

Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res (1988) 7.30

Association of cancer with AIDS-related immunosuppression in adults. JAMA (2001) 6.80

Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. Science (1986) 6.53

Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene. Science (1985) 6.48

Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science (1997) 5.91

Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS. Science (1984) 5.43

A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science (1982) 5.30

Spectrum of AIDS-associated malignant disorders. Lancet (1998) 5.30

Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science (1992) 5.25

Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins. J Virol (1987) 5.03

Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med (2001) 4.98

Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome. Br Med J (Clin Res Ed) (1984) 4.39

Snuff dipping and oral cancer among women in the southern United States. N Engl J Med (1981) 4.33

Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications. JAMA (1985) 4.26

Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24. J Virol (1988) 4.06

A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med (1989) 4.04

HIV transmission through breastfeeding: a study in Malawi. JAMA (1999) 4.00

Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC) Science (1998) 3.86

Sjögren's syndrome (Sicca syndrome): current issues. Ann Intern Med (1980) 3.81

Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst (2000) 3.77

Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome. Lancet (1984) 3.77

Natural antibodies to the structural core protein (p24) of the human T-cell leukemia (lymphoma) retrovirus found in sera of leukemia patients in Japan. Proc Natl Acad Sci U S A (1982) 3.75

X-linked B-lymphocyte immune defect in CBA/HN mice. I. Studies of the function and composition of spleen cells. J Exp Med (1975) 3.70

Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J Virol (1994) 3.70

Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis (1999) 3.69

Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science (1998) 3.60

Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA (1996) 3.50

HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS. Science (1984) 3.50

HTLV-III in cells cultured from semen of two patients with AIDS. Science (1984) 3.47

Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol (1996) 3.47

Epidermal Langerhans cells--a target for HTLV-III/LAV infection. J Invest Dermatol (1987) 3.41

Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Science (1986) 3.31

A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol (1984) 3.21

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation (2001) 3.15

Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region. JAMA (1986) 3.05

Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med (1989) 3.03

Immunological and chemical analysis of P6, the carboxyl-terminal fragment of HIV P15. AIDS Res Hum Retroviruses (1987) 3.03

Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J Immunol (1981) 3.02

Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml. J Infect Dis (2001) 2.95

Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS. N Engl J Med (1985) 2.95

Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen. Proc Natl Acad Sci U S A (1981) 2.86

Monoclonal origin of multicentric Kaposi's sarcoma lesions. N Engl J Med (1997) 2.81

Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation (1998) 2.77

The virus of Japanese adult T-cell leukaemia is a member of the human T-cell leukaemia virus group. Nature (1982) 2.75

Immunological properties of a type C retrovirus isolated from cultured human T-lymphoma cells and comparison to other mammalian retroviruses. J Virol (1981) 2.72

HTLV-III in symptom-free seronegative persons. Lancet (1984) 2.71

Structure of HLA antigens: amino-acid and carbohydrate compositions and NH2-terminal sequences of four antigen preparations. Proc Natl Acad Sci U S A (1976) 2.71

Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation (1999) 2.68

Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation (1999) 2.59

Natural history of HIV-1 cell-free viremia. JAMA (1995) 2.58

Primary structure analysis of the major internal protein p24 of human type C T-cell leukemia virus. Proc Natl Acad Sci U S A (1982) 2.57

Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA (1998) 2.55

Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. N Engl J Med (1985) 2.54

The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst (1998) 2.53

High risk of HIV-1 infection for first-born twins. The International Registry of HIV-exposed Twins. Lancet (1991) 2.51

Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis (2001) 2.47

Detection of human anti-HTLV-III antibodies by indirect immunofluorescence using fixed cells. Transfusion (1985) 2.45

Primary human T-lymphotropic virus type III infection. Ann Intern Med (1985) 2.40

Genetic polymorphism in CX3CR1 and risk of HIV disease. Science (2000) 2.38

Structure of crossreactive human histocompatibility antigens HLA-A28 and HLA-A2: possible implications for the generation of HLA polymorphism. Proc Natl Acad Sci U S A (1982) 2.36

Coronal caries in the primary and permanent dentition of children and adolescents 1-17 years of age: United States, 1988-1991. J Dent Res (1996) 2.36

Therapy may explain recent deficits in AIDS incidence. J Acquir Immune Defic Syndr (1990) 2.35

Appendectomy and subsequent risk of inflammatory bowel diseases. Surgery (2001) 2.35

Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation. J Immunol (1981) 2.30

Trends in HIV incidence among young adults in the United States. JAMA (1998) 2.28

Epidemiology of human T-cell leukemia/lymphoma virus. J Infect Dis (1983) 2.26

Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources. Proc Natl Acad Sci U S A (1985) 2.26

Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci U S A (2000) 2.25

Reverse transcriptase activity of human acute leukaemic cells: purification of the enzyme, response to AMV 70S RNA, and characterization of the DNA product. Nat New Biol (1972) 2.25

The AIDS problem in Africa. Lancet (1986) 2.25

Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci U S A (2000) 2.24

Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann Intern Med (1987) 2.24

Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer (1989) 2.24

Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly. AIDS Res Hum Retroviruses (1990) 2.15

Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet (2005) 2.13

Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J Natl Cancer Inst (1997) 2.12

B-lymphocyte alloantigens associated with systemic lupus erythematosus. N Engl J Med (1978) 2.11

Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation (1996) 2.10

Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: development of immunologic and clinical abnormalities. A longitudinal study. Ann Intern Med (1986) 2.06

Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med (2001) 2.05

Dental HIV transmission? Nature (1993) 2.04

Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer (1980) 2.04